Agenus announced updated Phase 1 data and progress botensilimab/balstilimab combination in metastatic MSS colorectal cancer

Agenus announced updated Phase 1 data and progress botensilimab/balstilimab combination in metastatic MSS colorectal cancer

Agenus shared on LinkedIn:

“Today we announced updated Phase 1 data and progress on our investigational botensilimab/balstilimab combination in patients with metastatic MSS colorectal cancer. Get the latest.”

Source: Agenus/LinkedIn

Agenus Balstilimab botensilimab cancer metastatic MSS colorectal cancer OncoDaily Oncology Phase 1 data